Atlas Trials

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

Clinical trial NCT03181477 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03181477
Sponsor
Centre Georges Francois Leclerc
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Glioblastoma, Adult
Start date
2017-04-07
Primary completion
2023-09-02
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.